Form 4 Tracker
LIGAND PHARMACEUTICALS INC
LGND

40 insider filings · Latest: Oct 2, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 2, 2026Oct 6 8:35 PMAndrew ReardonCLO & Secretary
Sale
5,000$304.07$1.5M31,854(D)

View →

Sep 10, 2026Sep 14 8:59 PMMartine ZimmermannDirector
Sale
1,200$285.00$342.0K3,897(D)

View →

Sep 10, 2026Sep 10 8:01 PMMARTINE ZIMMERMANN
Proposed Sale
1,200$285.00$342.0K—

View →

Sep 3, 2026Sep 8 10:34 PMAndrew ReardonCLO & Secretary
Sale
5,000$286.09$1.4M36,514(D)

View →

Sep 3, 2026Sep 3 8:40 PMANDREW REARDON
Proposed Sale
15,000$286.92$4.3M—

View →

Aug 12, 2026Aug 14 9:05 PMOctavio EspinozaChief Financial Officer
Sale
31,641$292.07$9.2M27,696(D)

View →

Aug 12, 2026Aug 14 9:04 PMJason HaasDirector
Sale
7,138$292.81$2.1M3,981(D)

View →

Aug 12, 2026Aug 12 8:33 PMOCTAVIO ESPINOZA
Proposed Sale
31,641$288.75$9.1M—

View →

Aug 12, 2026Aug 12 8:23 PMJason Haas
Proposed Sale
7,138$292.81$2.1M—

View →

Aug 3, 2026Aug 4 10:42 PMAndrew ReardonCLO & Secretary
Sale
5,000$288.99$1.4M41,514(D)

View →

Jul 1, 2026Jul 6 9:11 PMAndrew ReardonCLO & Secretary
Sale
5,000$313.28$1.6M41,514(D)

View →

Jul 1, 2026Jul 1 8:57 PMANDREW REARDON
Proposed Sale
10,000$316.09$3.2M—

View →

Jun 16, 2026Jun 18 12:37 PMStephen L SabbaDirector
Sale
2,145$254.00$544.8K33,629(D)

View →

Jun 16, 2026Jun 16 8:30 PMSTEPHEN L. SABBA
Proposed Sale
2,145$254.00$544.8K—

View →

Jun 12, 2026Jun 16 1:06 AMJason HaasDirector
Sale
6,461$255.58$1.7M4,981(D)

View →

Jun 11, 2026Jun 12 9:27 PMJason AryehDirector
Sale
4,500$250.00$1.1M102,580(D)

View →

Jun 10, 2026Jun 12 9:27 PMJason AryehDirector
Sale
500$250.00$125.0K107,080(D)

View →

Jun 10, 2026Jun 12 9:26 PMJohn L LamattinaDirector
Sale
4,591$250.88$1.2M26,969(D)

View →

Jun 12, 2026Jun 12 8:09 PMJASON HAAS
Proposed Sale
6,461$256.00$1.7M—

View →

Jun 11, 2026Jun 11 4:21 PMAryeh Jason
Proposed Sale
4,500$249.97$1.1M—

View →

Page 1 of 4

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 2, 2026Oct 6 8:35 PMAndrew ReardonCLO & Secretary
Option Exercise
340$52.2729,104(D)

View →

Aug 12, 2026Aug 14 9:05 PMOctavio EspinozaChief Financial Officer
Option Exercise
31,641$70.040(D)

View →

Aug 12, 2026Aug 14 9:04 PMJason HaasDirector
Option Exercise
6,138$51.560(D)

View →

Aug 3, 2026Aug 4 10:42 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2729,444(D)

View →

Jul 1, 2026Jul 6 9:11 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2734,444(D)

View →

Jun 16, 2026Jun 18 12:37 PMStephen L SabbaDirector
Option Exercise
2,145$66.130(D)

View →

Jun 12, 2026Jun 16 1:06 AMJason HaasDirector
Option Exercise
4,000$51.566,138(D)

View →

Jun 5, 2026Jun 12 9:27 PMJason AryehDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:42 PMMartine ZimmermannDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:41 PMStephen L SabbaDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:41 PMJohn L LamattinaDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:40 PMJohn W KozarichDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:35 PMJason HaasDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:35 PMNancy Ryan GrayDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 1, 2026Jun 2 10:22 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2739,444(D)

View →

May 27, 2026May 28 11:43 PMOctavio EspinozaChief Financial Officer
Option Exercise
1,736$63.6217,407(D)

View →

May 13, 2026May 15 1:08 AMJohn W KozarichDirector
Option Exercise
1,575$69.510(D)

View →

May 12, 2026May 15 1:08 AMJohn W KozarichDirector
Option Exercise
459$69.511,575(D)

View →

May 1, 2026May 5 12:20 AMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2744,444(D)

View →

Apr 1, 2026Apr 2 10:56 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2749,444(D)

View →

Page 1 of 2

Next →